换一批
换一批HER2-low expression does not affect the clinical outcomes of metastatic breast cancer treated with CDK4/6 inhibitor: A real-world study.
第一作者：
Yingbo,Shao
第一单位：
Department of Breast Oncology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.
作者：
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);细胞周期蛋白依赖激酶4(Cyclin-Dependent Kinase 4);女(雌)性(Female);人类(Humans);原位杂交, 荧光(In Situ Hybridization, Fluorescence);受体, 雌激素(Receptors, Estrogen);回顾性研究(Retrospective Studies)
DOI
10.3389/fendo.2022.1000704
PMID
36060981
发布时间
2022-09-13
- 浏览0
Frontiers in endocrinology
1000704页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
